4//SEC Filing
TC Group Cayman Investment Holdings, L.P. 4
Accession 0001493152-24-031632
CIK 0001906324other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:30 PM ET
Size
25.0 KB
Accession
0001493152-24-031632
Insider Transaction Report
Form 4
QuidelOrtho CorpQDEL
Carlyle Group Inc.
10% Owner
Transactions
- Sale
Common Stock
2024-08-09$41.60/sh−67,790$2,820,105→ 8,260,183 total(indirect: See footnotes) - Sale
Common Stock
2024-08-09$40.81/sh−6,344$258,876→ 8,327,973 total(indirect: See footnotes)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $40.9885. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Reflects ordinary shares held of record by Carlyle Partners VI Cayman Holdings, L.P. (the "Carlyle Investor"). The Carlyle Group Inc., a publicly traded company listed on Nasdaq, is the sole member of Carlyle Holdings II GP L.L.C., which is the managing member of Carlyle Holdings II L.L.C., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the general partner of TC Group Cayman Investment Holdings, L.P., which is the general partner of TC Group Cayman Investment Holdings Sub L.P., which is the sole member of TC Group VI Cayman, L.L.C., which is the general partner of TC Group VI Cayman, L.P., which is the general partner of the Carlyle Investor. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by the Carlyle Investor. Each of them disclaims beneficial ownership of such securities.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.01 to $41.89. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
QuidelOrtho Corp
CIK 0001906324
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001475444
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:30 PM ET
- Size
- 25.0 KB